
ALX Oncology Holdings Inc.: shareholders and insiders
Price
$1.06
November 20, 2026Market cap $140M
What Ploutos Investor adds for ALX Oncology
Part of Ploutos Investor, €9.99 a month
- The full history: 8 fiscal years, from 2018
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors from Nov 22, 2025 to Aug 18, 2026, from their own Form 4 filings.
Bought on the market
$5.0M
1 person
Sold on the market
$42.6K
3 people
From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $5.0M by 1 person·sold $42.6K by 3 people
- 2025: no buys, no sales
- 2026: bought $5.0M by 1 person, sold $42.6K by 3 people
- Aug 17, 2026Jason LettmannCHIEF EXECUTIVE OFFICERKind
- Aug 17, 2026Shelly WongSVP, FINANCE AND CAOKind
- Jul 1, 2026Shelly WongSVP, FINANCE AND CAOKind
- Mar 19, 2026Shelly PintoSVP, FINANCE AND CAOKind
- Mar 19, 2026Jason LettmannCHIEF EXECUTIVE OFFICERKind
- Feb 18, 2026Shelly PintoSVP, FINANCE AND CAOKind
- Feb 2, 2026Corey S GoodmanKind
- Jan 6, 2026Shelly PintoSVP, FINANCE AND CAOKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Jason LettmannCHIEF EXECUTIVE OFFICER | 2,230 | $1.93 | $4.3K | Form 4 | |
| Aug 17, 2026 | Shelly WongSVP, FINANCE AND CAO | 573 | $1.93 | $1.1K | Form 4 | |
| Jul 1, 2026 | Shelly WongSVP, FINANCE AND CAO | 1,404 | $2.04 | $2.9K | Form 4 | |
| Mar 19, 2026 | Shelly PintoSVP, FINANCE AND CAO | 903 | $2.17 | $2.0K | Form 4 | |
| Mar 19, 2026 | Jason LettmannCHIEF EXECUTIVE OFFICER | 12.3K | $2.17 | $26.7K | Form 4 | |
| Feb 18, 2026 | Shelly PintoSVP, FINANCE AND CAO | 565 | $2.27 | $1.3K | Form 4 | |
| Feb 2, 2026 | Corey S Goodman | 3.18M | $1.57 | $5.0M | Form 4 | |
| Jan 6, 2026 | Shelly PintoSVP, FINANCE AND CAO | 3,925 | $1.11 | $4.4K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jul 6, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by ALXO's officers and directors from 2020 up to November 21, 2025, 6 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 1 more, back to 2020
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- venBio Global Strategic Fund, L.P.with 6 more personsShare of class9.99%
- RA Capital Management, L.P.with 3 more personsShare of class9.90%
- Redmile Group, LLCwith 2 more personsShare of class6.80%
- HBM Healthcare Investments (Cayman) Ltd.Share of class6.50%
- BlackRock, Inc.Share of class5.40%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| venBio Global Strategic Fund, L.P.with 6 more persons | 9.99% | 12.93M | Oct 16, 20262 filings since Feb 4, 2026 | 13D/A | |
| RA Capital Management, L.P.with 3 more persons | 9.90% | 13.12M | Feb 9, 2026 | 13G | |
| Redmile Group, LLCwith 2 more persons | 6.80% | 9.21M | May 15, 20262 filings since Aug 14, 2025 | 13G/A | |
| HBM Healthcare Investments (Cayman) Ltd. | 6.50% | 8.59M | May 15, 20263 filings since Dec 27, 2024 | 13G/A | |
| BlackRock, Inc. | 5.40% | 7.33M | Jul 27, 2026 | 13G |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
venBio Global Strategic Fund, L.P.10.0%From the filing of Oct 16, 2026
Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The responses to Items 3 and 6 of this Amendment No. 2 are incorporated by reference herein. Mr. Goodman resigned from the Issuer's board of directors effective June 29, 2026.
From the filing of Oct 16, 2026
Fell to 5% or less (5)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter
- Citadel Advisors (Griffin)In the quarter
- Millennium Mgmt (Englander)In the quarter+53%
- Renaissance TechnologiesIn the quarter-24%
- AQR CapitalIn the quarter
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | 36.1K | $100.0K | 0.00% | |
| Citadel Advisors (Griffin) | 166.7K | $200.0K | 0.00% | |
| Millennium Mgmt (Englander) | 2.36M | +53% | $3.3M | 0.00% |
| Renaissance Technologies | 459.0K | -24% | $600.0K | 0.00% |
| AQR Capital | 1.21M | $1.7M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 4.54% of its shares outstanding were held short, +5.3% since the report before.
- Shares held short
- 5.98M
- 4.54%
- Since the report before5.67M on Sep 30, 2026
- +5.3%
- 3.6
- 1.65M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 43%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 3.82M
- Nov 15, 2023: Shares held short 3.90M
- Nov 30, 2023: Shares held short 3.92M
- Dec 15, 2023: Shares held short 4.04M
- Dec 29, 2023: Shares held short 3.77M
- Jan 12, 2024: Shares held short 3.69M
- Jan 31, 2024: Shares held short 3.62M
- Feb 15, 2024: Shares held short 3.53M
- Feb 29, 2024: Shares held short 3.48M
- Mar 15, 2024: Shares held short 2.91M
- Mar 28, 2024: Shares held short 3.12M
- Apr 15, 2024: Shares held short 3.69M
- Apr 30, 2024: Shares held short 3.16M
- May 15, 2024: Shares held short 3.36M
- May 31, 2024: Shares held short 2.91M
- Jun 14, 2024: Shares held short 4.24M
- Jun 28, 2024: Shares held short 5.51M
- Jul 15, 2024: Shares held short 7.75M
- Jul 31, 2024: Shares held short 9.08M
- Aug 15, 2024: Shares held short 9.28M
- Aug 30, 2024: Shares held short 9.98M
- Sep 13, 2024: Shares held short 9.99M
- Sep 30, 2024: Shares held short 9.32M
- Oct 15, 2024: Shares held short 9.59M
- Oct 31, 2024: Shares held short 7.84M
- Nov 15, 2024: Shares held short 7.23M
- Nov 29, 2024: Shares held short 7.17M
- Dec 13, 2024: Shares held short 8.39M
- Dec 31, 2024: Shares held short 7.60M
- Jan 15, 2025: Shares held short 7.83M
- Jan 31, 2025: Shares held short 5.99M
- Feb 14, 2025: Shares held short 6.45M
- Feb 28, 2025: Shares held short 5.89M
- Mar 14, 2025: Shares held short 6.39M
- Mar 31, 2025: Shares held short 6.30M
- Apr 15, 2025: Shares held short 6.14M
- Apr 30, 2025: Shares held short 6.05M
- May 15, 2025: Shares held short 5.83M
- May 30, 2025: Shares held short 5.69M
- Jun 13, 2025: Shares held short 5.44M
- Jun 30, 2025: Shares held short 4.87M
- Jul 15, 2025: Shares held short 4.39M
- Jul 31, 2025: Shares held short 4.48M
- Aug 15, 2025: Shares held short 1.63M
- Aug 29, 2025: Shares held short 1.82M
- Sep 15, 2025: Shares held short 1.58M
- Sep 30, 2025: Shares held short 1.34M
- Oct 15, 2025: Shares held short 1.86M
- Oct 31, 2025: Shares held short 1.84M
- Nov 14, 2025: Shares held short 1.78M
- Nov 28, 2025: Shares held short 793.9K
- Dec 15, 2025: Shares held short 1.05M
- Dec 31, 2025: Shares held short 985.2K
- Jan 15, 2026: Shares held short 1.09M
- Jan 30, 2026: Shares held short 1.14M
- Feb 13, 2026: Shares held short 1.17M
- Feb 27, 2026: Shares held short 1.17M
- Mar 13, 2026: Shares held short 1.22M
- Mar 31, 2026: Shares held short 2.22M
- Apr 15, 2026: Shares held short 2.05M
- Apr 30, 2026: Shares held short 2.21M
- May 15, 2026: Shares held short 1.38M
- May 29, 2026: Shares held short 1.71M
- Jun 15, 2026: Shares held short 2.59M
- Jun 30, 2026: Shares held short 6.32M
- Jul 15, 2026: Shares held short 7.46M
- Jul 31, 2026: Shares held short 7.72M
- Aug 14, 2026: Shares held short 7.61M
- Aug 31, 2026: Shares held short 7.06M
- Sep 15, 2026: Shares held short 6.27M
- Sep 30, 2026: Shares held short 5.67M
- Oct 15, 2026: Shares held short 5.98M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading42.8% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 42.8% of the shares in the reported trades were short sales, against 39.4% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 42.8%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 39.4%
- Change
- +3.4 pts
- Short sales a dayon average, of 525.2K shares
- 225.0K
- More than atof 3,666 US-listed companies, same days
- 26%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 25.6%
- Oct 15, 2026: Short sales 39.4%
- Oct 16, 2026: Short sales 49.7%
- Oct 19, 2026: Short sales 59.9%
- Oct 20, 2026: Short sales 48.8%
- Oct 21, 2026: Short sales 26.9%
- Oct 22, 2026: Short sales 84.6%
- Oct 23, 2026: Short sales 70%
- Oct 26, 2026: Short sales 83.1%
- Oct 27, 2026: Short sales 22.1%
- Oct 28, 2026: Short sales 18.1%
- Oct 29, 2026: Short sales 68.3%
- Oct 30, 2026: Short sales 78%
- Nov 2, 2026: Short sales 52.5%
- Nov 3, 2026: Short sales 67.8%
- Nov 4, 2026: Short sales 57.2%
- Nov 5, 2026: Short sales 45.8%
- Nov 6, 2026: Short sales 58.6%
- Nov 9, 2026: Short sales 73.1%
- Nov 10, 2026: Short sales 74.2%
- Nov 11, 2026: Short sales 78.4%
- Nov 12, 2026: Short sales 81.9%
- Nov 13, 2026: Short sales 54.7%
- Nov 16, 2026: Short sales 46.2%
- Nov 17, 2026: Short sales 64.6%
- Nov 18, 2026: Short sales 42.4%
- Nov 19, 2026: Short sales 8.6%
- Nov 20, 2026: Short sales 56.5%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Corey S GoodmanDirector,TenPercentOwnerDirectly–
- Jaume PonsPRESIDENT & CSODirectly579.4K
- Sophia RandolphCHIEF MEDICAL OFFICERDirectly325.7K
- Jason LettmannCHIEF EXECUTIVE OFFICERDirectly294.4K
- Peter S GarciaCHIEF FINANCIAL OFFICERDirectly122.3K
- Shelly WongSVP, FINANCE AND CAODirectly87.8K
- Harish ShantharamChief Financial OfficerDirectly75.0K
- Rekha HemrajaniDirectorDirectly33.0K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Corey S GoodmanDirector,TenPercentOwner | – | 8.45M | Feb 2, 2026 | Form 4 |
| Jaume PonsPRESIDENT & CSO | 579.4K | – | Feb 19, 2025 | Form 4 |
| Sophia RandolphCHIEF MEDICAL OFFICER | 325.7K | – | Aug 14, 2024 | Form 4 |
| Jason LettmannCHIEF EXECUTIVE OFFICER | 294.4K | – | Aug 17, 2026 | Form 4 |
| Peter S GarciaCHIEF FINANCIAL OFFICER | 122.3K | – | Jun 13, 2024 | Form 4 |
| Shelly WongSVP, FINANCE AND CAO | 87.8K | – | Aug 17, 2026 | Form 4 |
| Harish ShantharamChief Financial Officer | 75.0K | – | Aug 18, 2025 | Form 4 |
| Rekha HemrajaniDirector | 33.0K | – | Dec 2, 2024 | Form 4 |
A lower bound: it counts only the 8 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.05%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.01%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.01%
- IWMiShares Russell 2000 ETFWeight in the fund0.01%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
6 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 61
- Q4 2025: Managers 57
- Q1 2026: Managers 70
- Q2 2026: Managers 94
Institutional investors by quarter
The fund managers holding ALXO, quarter by quarter, from Q3 2020 to Q2 2025, 20 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 94 managers held 106M shares, worth $219M. During the quarter 37 opened a position, 13 closed one, 25 added and 10 trimmed.
The largest holders, Q2 2026
- Ra Capital ManagementIn the quarter
- venBio PartnersIn the quarter
- BlackRockIn the quarter×16.5
- Redmile GroupIn the quarter-7.2%
- BlackstoneIn the quarter+13%
- Driehaus Capital ManagementIn the quarter+5.1%
- Silverarc Capital ManagementIn the quarter
- TCG Crossover ManagementIn the quarter-57%
- Vanguard Capital ManagementIn the quarter+19%
- Vivo CapitalIn the quarter
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Ra Capital Management | 13.01M | $27M | |
| venBio Partners | 12.88M | $27M | |
| BlackRock | 7.40M | ×16.5 | $15M |
| Redmile Group | 7.39M | -7.2% | $15M |
| Blackstone | 6.59M | +13% | $14M |
| Driehaus Capital Management | 6.03M | +5.1% | $12M |
| Silverarc Capital Management | 5.74M | $12M | |
| TCG Crossover Management | 5.66M | -57% | $12M |
| Vanguard Capital Management | 4.97M | +19% | $10M |
| Vivo Capital | 3.18M | $6.6M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do ALX Oncology's filings show?
Who buys and sells is one part of ALX Oncology's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have ALXO's insiders bought or sold?
From Jul 6, 2026 to Aug 18, 2026 ALX Oncology's insiders bought 0 and sold $8.3K of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold ALXO?
5 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $3.3M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.